Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
about
Autoantibodies against C1q as a Diagnostic Measure of Lupus Nephritis: Systematic Review and Meta-analysisImmune complex signatures of patients with active and inactive SLE revealed by multiplex protein binding analysis on antigen microarrays.Serum levels and renal deposition of C1q complement component and its antibodies reflect disease activity of lupus nephritisRenal involvement in autoimmune connective tissue diseases.Application of fluorescent monocytes for probing immune complexes on antigen microarrays.Glomerular C1q deposition and serum anti-C1q antibodies in anti-glomerular basement membrane disease.Detection of autoantibodies in a point-of-care rheumatology setting.Anti-C1q antibodies as a follow-up marker in SLE patientsCo-Positivity for Anti-dsDNA, -Nucleosome and -Histone Antibodies in Lupus Nephritis Is Indicative of High Serum Levels and Severe Nephropathy.Association between the Presence of Autoantibodies Targeting Ficolin-3 and Active Nephritis in Patients with Systemic Lupus ErythematosusAntibodies against C1q Are a Valuable Serological Marker for Identification of Systemic Lupus Erythematosus Patients with Active Lupus NephritisAnti-C1q antibodies and their association with complement components in Indian systemic lupus erythematosus patients.Evaluation of Endothelial Cell Adhesion Molecules and Anti-C1q Antibody in Discriminating between Active and Non-Active Systemic Lupus ErythematosusUrine biomarkers in juvenile-onset SLE nephritis.Biomarkers in lupus nephritis.Antibodies Against Complement Components: Relevance for the Antiphospholipid Syndrome-Biomarkers of the Disease and Biopharmaceuticals.The Usefulness of Endothelial Cell Adhesion Molecules and Anti-C1q Antibody in Monitoring Systemic Lupus Erythematosus Disease Activity.Anti-C1q antibody in patients with lupus nephritic flare: 18-month follow-up and a nested case-control study.Combination of anti-C1q and anti-dsDNA antibodies is associated with higher renal disease activity and predicts renal prognosis of patients with lupus nephritis.Simultaneous positivity for anti-DNA, anti-nucleosome and anti-histone antibodies is a marker for more severe lupus nephritis.Circadian clock cryptochrome proteins regulate autoimmunity.Anti-C1q autoantibodies as markers of renal involvement in childhood-onset systemic lupus erythematosus.Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosus.Autoantibodies against complement components in systemic lupus erythematosus - role in the pathogenesis and clinical manifestations.Nephritogenic-antinephritogenic antibody network in lupus glomerulonephritis.PTX3, Anti-PTX3, and Anti-C1q Autoantibodies in Lupus GlomerulonephritisDiagnostic value of serum anti-C1q antibodies in patients with lupus nephritis: a meta-analysis
P2860
Q33775707-B9E2D69D-2A93-45F5-96F0-DA6E8D098AF4Q34416171-C24F1C6E-8FC7-42B6-A181-87583860B784Q34627394-39BA2755-3552-4254-83FD-2356274C1B21Q34654954-278D19FA-CB02-4244-94F2-D61A751A36F2Q34988379-4896F43B-CCA0-45ED-B3C0-B58E45924EB8Q34993153-55A2FE05-22B0-44A8-80EE-D4736632A77DQ35309576-B05F6CF2-55FC-44BD-B48A-2288EB19DEEAQ35448756-C6404B74-1180-49AB-A827-8BAF04AEF3DEQ35806070-1969BE9E-2D7A-42A6-80B3-9624F7C00358Q36134326-CAA8A98B-E7C5-4B36-897A-4DC22A8A2846Q36208980-F7D05F1E-9A20-4F5C-9439-88949A7043F9Q36529304-098B627B-B29A-455A-9926-E803489CF01CQ37069721-58B2E7B2-A07E-43C7-80EB-42497E200AFEQ38010347-67D2ABCF-117F-4031-BB1E-8DEEBEE53C05Q38425837-2A21C0BC-3326-4F6C-AC1F-FF1899585751Q38718092-A79B27AD-2FB7-4440-A691-49D06E02E101Q39646545-EFAE982D-DFC8-4510-8D66-42DA77762948Q41377503-BAD03C92-7BC6-4ED2-B5C3-3D3FC66DE520Q43790196-CD7360B8-72C6-4B36-ADF9-B1DA6A483877Q44439756-423E69D3-662A-488E-99BA-8EB79303DD2CQ46273899-DEEA6FD9-7E6E-4F6F-AAB4-C5D0EA148990Q48361761-6B5F869A-067E-490D-9F29-1BFBB814FFF6Q51724929-5328F876-0BCD-4EA0-AC85-0BEEA0FE9FFBQ52447526-095DBF7B-DDA5-4C49-B2E6-97B6F68B381CQ53141150-0D38BA2E-82B4-4D6E-B394-E33F1D73A626Q56942132-6A7566D9-BDBC-4C3A-8700-A43F32CC118EQ57603229-27366BA7-C196-4B08-A6DB-3EF39483C27B
P2860
Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Anti-C1q antibodies are associ ...... y of 126 consecutive patients.
@en
Anti-C1q antibodies are associ ...... y of 126 consecutive patients.
@nl
type
label
Anti-C1q antibodies are associ ...... y of 126 consecutive patients.
@en
Anti-C1q antibodies are associ ...... y of 126 consecutive patients.
@nl
prefLabel
Anti-C1q antibodies are associ ...... y of 126 consecutive patients.
@en
Anti-C1q antibodies are associ ...... y of 126 consecutive patients.
@nl
P2093
P2860
P356
P1476
Anti-C1q antibodies are associ ...... y of 126 consecutive patients.
@en
P2093
Hisashi Yamanaka
Kohei Miyake
Manabu Kawamoto
Masako Hara
Sayumi Baba
Takahisa Gono
Yasuhiro Katsumata
Yasushi Kawaguchi
Yuko Okamoto
P2860
P304
P356
10.1002/ART.30401
P577
2011-08-01T00:00:00Z